Sanbio, Inc.
Records under this name other than the patents Sanbio, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 25 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,828,593 | Methods and Compositions for Treatment of Traumatic Brain Injury and for Modulation of Migration of Neurogenic Cells now held by University of South Florida In force · High confidence | In force | High confidence | |
| US 10,626,389 | Methods and Compositions for Modulation of Migration of Neurogenic Cells now held by University of South Florida In force · High confidence | In force | High confidence | |
| US 7,682,825 | Differentiation of Bone Marrow Stromal Cells to Neural Cells or Skeletal Muscle Cells by Introduction of Notch Gene Term ended Term ended Feb 19, 2026 · High confidence | Term ended | Term ended Feb 19, 2026 | High confidence |
| US 10,316,288 | Neural Regenerating Cells with Alterations in DNA Methylation Surrendered on reissue Surrendered on reissue Oct 14, 2025 · High confidence | Surrendered on reissue | Surrendered on reissue Oct 14, 2025 | High confidence |
| US 9,441,199 | Cells Exhibiting Neuronal Progenitor Cell Characteristics and Methods of Making Them Term ended Term ended Apr 7, 2025 · Medium confidence | Term ended | Term ended Apr 7, 2025 | Medium confidence |
| US 9,399,046 | Treatment of CNS disorders using descendants of MSCs expressing an exogenous Notch intracellular domain Term ended Ended no later than Jul 15, 2023 · Low confidence | Term ended | Ended no later than Jul 15, 2023 | Low confidence |
| US 10,196,605 | Treatment of CNS Disorders Using Descendants of MSCS Expressing an Exogenous Notch Intracellular Domain Term ended Term ended Feb 6, 2023 · Medium confidence | Term ended | Term ended Feb 6, 2023 | Medium confidence |
| US 11,512,284 | Neural precursor cells expressing exogenous Notch intracellular domain Term ended Term ended Feb 6, 2023 · Medium confidence | Term ended | Term ended Feb 6, 2023 | Medium confidence |
| US 6,989,271 | Schwann Cells Originating in Myeloid Interstitial Cells Term ended Term ended Jun 21, 2022 · High confidence | Term ended | Term ended Jun 21, 2022 | High confidence |
| US 8,785,190 | Methods and Compositions for Modulating Peripheral Immune Function Surrendered on reissue Surrendered on reissue May 2, 2017 · Medium confidence | Surrendered on reissue | Surrendered on reissue May 2, 2017 | Medium confidence |